Stress-induced dissociations between intracellular calcium signaling and insulin secretion in pancreatic islets

Cell Calcium

Volumn 57, Issue 5-6, 2015, Pages 366-375

  Qureshi, Farhan M ^a,b   Dejene, Eden A ^a,b   Corbin, Kathryn L ^a   Nunemaker, Craig S ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Beta cells; Calcium; Chronic; Cytokines; Diabetes; Endoplasmic reticulum; ER stress; Free fatty acid; Glucotoxicity; High glucose; IL 1beta; IL 6; Insulin; Interleukin; Islets; Linoleate; Low grade inflammation; Oleate; Oxidative stress; Palmitate; Rotenone; Thapsigargin; Unfolded protein response

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; CYTOKINE; DIAZOXIDE; FATTY ACID; GLUCOSE; NIFEDIPINE; POTASSIUM CHLORIDE; ROTENONE; THAPSIGARGIN; CALCIUM; INSULIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL METABOLISM; CELL STIMULATION; CELL STRESS; CONTROLLED STUDY; DISSOCIATION; ENDOPLASMIC RETICULUM STRESS; GLUCOTOXICITY; INFLAMMATION; INSULIN RELEASE; LIPOTOXICITY; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; ANIMAL; ANIMAL MODEL; CYTOLOGY; DRUG EFFECTS; ENDOPLASMIC RETICULUM; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY; SECRETION (PROCESS);

ANIMALS; CALCIUM; CALCIUM SIGNALING; CYTOKINES; ENDOPLASMIC RETICULUM; FATTY ACIDS, NONESTERIFIED; GLUCOSE; INSULIN; ISLETS OF LANGERHANS; MICE; MODELS, ANIMAL; STRESS, PHYSIOLOGICAL;

EID: 84928586981     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2015.03.002     Document Type: Article

References (66)

1. Henquin J.C. Regulation of insulin secretion: a matter of phase control and amplitude modulation. Diabetologia 2009, 52:739-751.
2. Ramadan J.W., Steiner S.R., O'Neill C.M., Nunemaker C.S. The central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetes. Cell Calcium 2011, 50:481-490.
3. Dula S.B., Jecmenica M., Wu R., et al. Evidence that low-grade systemic inflammation can induce islet dysfunction as measured by impaired calcium handling. Cell Calcium 2010, 48:133-142.
4. Straub S.G., James R.F., Dunne M.J., Sharp G.W. Glucose activates both K(ATP) channel-dependent and K(ATP) channel-independent signaling pathways in human islets. Diabetes 1998, 47:758-763.
5. Komatsu M., Sato Y., Aizawa T., Hashizume K. KATP channel-independent glucose action: an elusive pathway in stimulus-secretion coupling of pancreatic beta-cell. Endocr. J. 2001, 48:275-288.
6. Henquin J.C. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 2000, 49:1751-1760.
7. Hoehn K.L., Salmon A.B., Hohnen-Behrens C., et al. Insulin resistance is a cellular antioxidant defense mechanism. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:17787-17792.
8. Li N., Brun T., Cnop M., Cunha D.A., Eizirik D.L., Maechler P. Transient oxidative stress damages mitochondrial machinery inducing persistent beta-cell dysfunction. J. Biol. Chem. 2009, 284:23602-23612.
9. 2+ in mouse islets of Langerhans. Am. J. Physiol. 1994, 266:E852-E862.
10. Eizirik D.L., Cardozo A.K., Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr. Rev. 2008, 29:42-61.
11. Kolb H., Mandrup-Poulsen T. The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia 2010, 53:10-20.
12. O'Neill C.M., Lu C., Corbin K.L., et al. Circulating levels of IL-1B+IL-6 cause ER stress and dysfunction in islets from prediabetic male mice. Endocrinology 2013, 154:3077-3088.
13. Kaiser N., Leibowitz G., Nesher R. Glucotoxicity and beta-cell failure in type 2 diabetes mellitus. J. Pediatr. Endocrinol. Metab. 2003, 16:5-22.
14. Weir G.C., Marselli L., Marchetti P., Katsuta H., Jung M.H., Bonner-Weir S. Towards better understanding of the contributions of overwork and glucotoxicity to the beta-cell inadequacy of type 2 diabetes. Diabetes Obes. Metab. 2009, 11(Suppl 4):82-90.
15. Watt M.J., Hoy A.J., Muoio D.M., Coleman R.A. Distinct roles of specific fatty acids in cellular processes: implications for interpreting and reporting experiments. Am. J. Physiol. Endocrinol. Metab. 2012, 302:E1-E3.
16. Sosenko J.M., Skyler J.S., Beam C.A., et al. Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants. Diabetes 2013, 62:4179-4183.
17. Del Prato S., Tiengo A. The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. Diabetes Metab. Res. Rev. 2001, 17:164-174.
18. Cheng K., Andrikopoulos S., Gunton J.E. First phase insulin secretion and type 2 diabetes. Curr. Mol. Med. 2013, 13:126-139.
19. Carter J.D., Dula S.B., Corbin K.L., Wu R., Nunemaker C.S. A practical guide to rodent islet isolation and assessment. Biol. Proced. Online 2009, 11:3-31.
20. Crim W.S., Wu R., Carter J.D., et al. AGI-1067, a novel antioxidant and anti-inflammatory agent, enhances insulin release and protects mouse islets. Mol. Cell. Endocrinol. 2010, 323:246-255.
21. Corbin K.L., Hall T.E., Haile R., Nunemaker C.S. A novel fluorescence imaging approach for comparative measurements of pancreatic islet function in vitro. Islets 2011, 3:14-20.
22. Jahanshahi P., Wu R., Carter J.D., Nunemaker C.S. Evidence of diminished glucose stimulation and endoplasmic reticulum function in nonoscillatory pancreatic islets. Endocrinology 2009, 150:607-615.
23. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985, 260:3440-3450.
24. 2+ stores and arachidonic acid metabolism. J. Clin. Invest. 1998, 101:1623-1632.
25. 2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells. Diabetes 2005, 54:452-461.
26. Malaisse W.J., Picton S., Malaisse-Lagae F., Sener A. Effects of high extracellular K(+) concentrations, diazoxide and/or Ca(2+) deprivation upon D-glucose metabolism in pancreatic islets. Biochim. Biophys. Acta 1999, 1451:255-262.
27. Ling Z., Pipeleers D.G. Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. J. Clin. Invest. 1996, 98:2805-2812.
28. Pertusa J.A., Nesher R., Kaiser N., Cerasi E., Henquin J.C., Jonas J.C. Increased glucose sensitivity of stimulus-secretion coupling in islets from Psammomys obesus after diet induction of diabetes. Diabetes 2002, 51:2552-2560.
29. Leloup C., Tourrel-Cuzin C., Magnan C., et al. Mitochondrial reactive oxygen species are obligatory signals for glucose-induced insulin secretion. Diabetes 2009, 58:673-681.
30. Wajchenberg B.L. Beta-cell failure in diabetes and preservation by clinical treatment. Endocr. Rev. 2007, 28:187-218.
31. Graciano M.F., Valle M.M., Kowluru A., Curi R., Carpinelli A.R. Regulation of insulin secretion and reactive oxygen species production by free fatty acids in pancreatic islets. Islets 2011, 3:213-223.
32. Back S.H., Kaufman R.J. Endoplasmic reticulum stress and type 2 diabetes. Annu. Rev. Biochem. 2012, 81:767-793.
33. Mizukami H., Takahashi K., Inaba W., et al. Involvement of oxidative stress-induced DNA damage, endoplasmic reticulum stress, and autophagy deficits in the decline of beta-cell mass in Japanese type 2 diabetic patients. Diabetes Care 2014, 37:1966-1974.
34. Mandrup-Poulsen T., Helqvist S., Molvig J., Wogensen L.D., Nerup J. Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus. Autoimmunity 1989, 4:191-218. discussion 219-34.
35. Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 2011, 11:98-107.
36. Imai Y., Dobrian A.D., Morris M.A., Nadler J.L. Islet inflammation: a unifying target for diabetes treatment?. Trends Endocrinol. Metab. 2013, 24:351-360.
37. Abdel-Halim S.M., Guenifi A., Khan A., et al. Impaired coupling of glucose signal to the exocytotic machinery in diabetic GK rats: a defect ameliorated by cAMP. Diabetes 1996, 45:934-940.
38. Hughes S.J., Faehling M., Thorneley C.W., Proks P., Ashcroft F.M., Smith P.A. Electrophysiological and metabolic characterization of single beta-cells and islets from diabetic GK rats. Diabetes 1998, 47:73-81.
39. Leahy J.L., Cooper H.E., Deal D.A., Weir G.C. Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions. J. Clin. Invest. 1986, 77:908-915.
40. Grill V., Bjorklund A. Overstimulation and beta-cell function. Diabetes 2001, 50(Suppl. 1):S122-S124.
41. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., Butler P.C. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003, 52:102-110.
42. Ahren B. Type 2 diabetes, insulin secretion and beta-cell mass. Curr. Mol. Med. 2005, 5:275-286.
43. Khaldi M.Z., Guiot Y., Gilon P., Henquin J.C., Jonas J.C. Increased glucose sensitivity of both triggering and amplifying pathways of insulin secretion in rat islets cultured for 1 wk in high glucose. Am. J. Physiol. Endocrinol. Metab. 2004, 287:E207-E217.
44. 2+-signaling in pancreatic beta-cells. Mol. Cell Endocrinol. 2003, 212:1-9.
45. Schnell S., Schaefer M., Schofl C. Free fatty acids increase cytosolic free calcium and stimulate insulin secretion from beta-cells through activation of GPR40. Mol. Cell Endocrinol. 2007, 263:173-180.
46. 2+ homeostasis in beta-cells. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E690-E701.
47. Listenberger L.L., Han X., Lewis S.E., et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:3077-3082.
48. Coll T., Eyre E., Rodriguez-Calvo R., et al. Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells. J. Biol. Chem. 2008, 283:11107-11116.
49. Zhao Y.F., Pei J., Chen C. Activation of ATP-sensitive potassium channels in rat pancreatic beta-cells by linoleic acid through both intracellular metabolites and membrane receptor signalling pathway. J. Endocrinol. 2008, 198:533-540.
50. Tian G., Sol E.R., Xu Y., Shuai H., Tengholm A. Impaired cAMP generation contributes to defective glucose-stimulated insulin secretion after long-term exposure to palmitate. Diabetes 2015, 64:904-915.
51. Zhou Y.P., Grill V.E. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J. Clin. Invest. 1994, 93:870-876.
52. Zhang Y., Xiao M., Niu G., Tan H. Mechanisms of oleic acid deterioration in insulin secretion: role in the pathogenesis of type 2 diabetes. Life Sci. 2005, 77:2071-2081.
53. Sako Y., Grill V.E. A 48-h lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 1990, 127:1580-1589.
54. Hoppa M.B., Collins S., Ramracheya R., et al. Chronic palmitate exposure inhibits insulin secretion by dissociation of Ca(2+) channels from secretory granules. Cell Metab. 2009, 10:455-465.
55. Warnotte C., Gilon P., Nenquin M., Henquin J.C. Mechanisms of the stimulation of insulin release by saturated fatty acids. A study of palmitate effects in mouse beta-cells. Diabetes 1994, 43:703-711.
56. Tian Y., Corkey R.F., Yaney G.C., Goforth P.B., Satin L.S., Moitoso de Vargas L. Differential modulation of L-type calcium channel subunits by oleate. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E1178-E1186.
57. 2+ in mouse pancreatic beta-cells. J. Physiol. (Lond.) 2001, 530:533-540.
58. 2+ sequestration in diabetic mouse islets of Langerhans. J. Biol. Chem. 1994, 269:18279-18282.
59. 2+ channels in endoplasmic reticulum stress and beta-cell death. Diabetes 2009, 58:422-432.
60. Li N., Ragheb K., Lawler G., et al. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J. Biol. Chem. 2003, 278:8516-8525.
61. Saadeh M., Ferrante T.C., Kane A., Shirihai O., Corkey B.E., Deeney J.T. Reactive oxygen species stimulate insulin secretion in rat pancreatic islets: studies using mono-oleoyl-glycerol. PLoS ONE 2012, 7:e30200.
62. Robertson R.P., Harmon J.S. Diabetes, glucose toxicity, and oxidative stress: a case of double jeopardy for the pancreatic islet beta cell. Free Radic. Biol. Med. 2006, 41:177-184.
63. Sarre A., Gabrielli J., Vial G., Leverve X.M., Assimacopoulos-Jeannet F. Reactive oxygen species are produced at low glucose and contribute to the activation of AMPK in insulin-secreting cells. Free Radic. Biol. Med. 2012, 52:142-150.
64. Takahashi H.K., Santos L.R., Roma L.P., et al. Acute nutrient regulation of the mitochondrial glutathione redox state in pancreatic beta-cells. Biochem. J. 2014, 460:411-423.
65. Martens G.A., Cai Y., Hinke S., Stange G., Van de Casteele M., Pipeleers D. Glucose suppresses superoxide generation in metabolically responsive pancreatic beta cells. J. Biol. Chem. 2005, 280:20389-20396.
66. Armann B., Hanson M.S., Hatch E., Steffen A., Fernandez L.A. Quantification of basal and stimulated ROS levels as predictors of islet potency and function. Am. J. Transpl. 2007, 7:38-47.